Screening for cystic fibrosis: The practice and the debate

European Journal of Pediatrics, Supplement

Volumn 162, Issue 1, 2003, Pages

  Bonham, James R ^a   Downing, Melanie ^a   Dalton, Ann ^a  

^a SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Outcome; Screening

Indexed keywords

DNA; TRYPSIN;

ANXIETY; CONFERENCE PAPER; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; EVALUATION; FOLLOW UP; GENETIC COUNSELING; GENETICS; GROWTH RATE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HETEROZYGOSITY; HUMAN; IMMUNOREACTIVITY; LABORATORY TEST; MEDICAL INFORMATION; MEDICAL PRACTICE; NEWBORN; NEWBORN SCREENING; PARENT; PHENYLKETONURIA; POPULATION RESEARCH; PRENATAL PERIOD; PRIORITY JOURNAL; SAMPLING; STATISTICAL SIGNIFICANCE; SWEAT;

EID: 0347320493     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1350-4     Document Type: Conference Paper

References (14)

1. Anderson DH (1938) Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathological study. Am J Dis Child 56: 334
2. Chatfield S, Owen G, Ryley HC, Williams J, Goodchild MC, Weller P (1991) Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 66: 29-33
3. Crossley JR, Elliot RB, Smith PA (1979) Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1: 472-474
4. Di Santi'Agnese PA, Darling RC, Perera GA, Shea A (1953) Abnormal composition of sweat in cystic fibrosis of the pancreas: clinical significance and relationship to the disease. Pediatrics 12: 549-563
5. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Hoffman G et al (1998) Assessment of the benefits, risks and costs of cystic fibrosis screening in Wisconsin, USA. Proceedings of the Fifth International Conference on Neonatal Screening for Cystic Fibrosis, pp 239-253.
6. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML (2001) Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 107: 1-13
7. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A et al (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080
8. Merelle ME, Lees CM, Nagelkerke AF, Dezateux C (2001) Newborn screening in cystic fibrosis. Cochrane Database System Rev 2: CD001402.
9. Rostenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Consensus Panel. J Pediatr 132: 589-595
10. Seybold P (2001) The customer revolution. Random House Business Books, London
11. Stephan U, Busch EW, Kollberg H, Hellsing K (1975) Cystic fibrosis testing by means of a test strip. Pediatrics 55: 35-38
12. Waters DL, Wilcken B, Irwing L, Van Asperen P, Mellis C, Simpson JJ, Gaskin KJ (1999) Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 80: F1-F7
13. Widdicombe JH, Welsh MJ, Finkbeiner WE (1985) Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. Proc Natl Acad Sci USA 82: 6167-6171
14. Wilson JMG, Junger G (1968) Principals and practice of screening for disease. Bol Oficina Sanit Panam 65: 281-293